Bacterin International, Inc.

Bacterin (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. For more information, please visit https://www.bacterin.com.

网站

https://www.bacterin.com

Bacterin International, Inc.的外部链接

所属行业

生物技术研究

规模

51-200 人

总部

Belgrade，MT

类型

上市公司

创立

1998

领域

Accredited Tissue Bank、Medical Device Company、Designs, Processes, Manufactures, and Markets advanced medical products、Low-dose gamma irradiation和Quality, safe, and clinically effective allografts